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EDITORIAL
Management of the cadaveric donor of a renal transplant:
More than optimizing renal perfusion?
Donor factors are important determinants of the transplant, these cytokines and adhesion molecules could
facilitate the entry of recipient leukocytes into the kidneyshort- and long-term outcomes of renal transplantation.
and thus acute rejection. Supporting this concept is theThis conclusion is supported by the similar fates of some
observation that there is increased acute rejection inpaired kidneys removed from the same cadaver donor
rodent models if the transplanted kidney is taken from[1, 2], and the superior survival of transplants from living
a brain-dead, as opposed to a living, donor. Furthermore,unrelated donors compared with cadaveric donors, de-
human renal transplants from living donors have lessspite the poorer donor-recipient HLA-matching of the
adhesion molecule expression, less inflammation [6] andformer [3]. A complete understanding of these donor
better outcomes [3] than those from cadavers. Acutefactors is elusive. Most studies have focused on the un-
brain death is also associated with profound neuroendo-derlying structural integrity of the donor kidney by exam-
crine dysregulation. Initially, massive release of catecholsining donor age, sex, nephron mass, etc., or by examining
may result in hypertension; then there may be insufficientrenal damage resulting from the hypotension and hypo-
catecholamines and thus hypotension [5, 7]. Consistentperfusion associated with the acute injury or trauma that
with the above hypothesis is the observation by Schnuellecaused the brain death of the cadaver donor.
et al that the salutary effect of catecholamines was mostAlthough the structural integrity of the donor kidney
pronounced in donors that had suffered acute traumaticis undeniably important, additional concepts are neces-
brain death.sary to understand the report of Schnuelle et al in this
Second, catecholamines may inhibit the inflammatoryissue of Kidney International [4]. These authors found
response of the kidney to injury, and thus decrease rejec-that treating cadaver donors with catecholamines re-
tion. Matzinger has emphasized the importance of injuryduced the incidence of acute rejection and improved
in initiating immune responses [8]. According to thisrenal allograft survival. As the authors note, in other
hypothesis, the immune system ordinarily encounters astudies, administration of catecholamines to cadaveric
multitude of non-self antigens in the air we inhale, thedonors has increased, decreased, or had no effect on
food we eat, and the objects we touch. Yet, these non-selfinitial allograft function and long-term outcomes. Poor
antigens are ignored. The immune system has evolved tooutcomes may have occurred when high-dose catechola-
be activated only after infections. Unlike innocuous non-mines were employed in the setting of severe cardiovas-
self antigens, non-self antigens of infectious pathogenscular collapse, or when other detrimental factors such
are associated with injury. It is the combination of injuryas advanced donor age or prolonged cold ischemia time
and non-self antigens, ordinarily seen during infections,were also present. A beneficial effect may result when
that activates an immune response. After transplanta-catecholamines improve renal perfusion. A remarkable
tion, the non-self antigens are the alloantigens of thefeature of the donors in the study by Schnuelle et al is
transplant, and the injury occurs during the transplanta-that those which did, and those which did not, receive
tion process—hypoperfusion in the donor, cold ischemiacatecholamines had the same good blood pressure and
during transport of the organ to the recipient, and warmurine output.
ischemia during the surgical anastomoses (9). Catechola-If the perfusion of the donor kidney is good, how
mines may diminish the injury by improving renal perfu-would catecholamines reduce rejection? One possibility
sion in hypotensive patients, and, as Schnuelle et al dis-is that catecholamines mitigate the detrimental effect
cuss, they may inhibit inflammation by inhibiting theof acute traumatic brain death on the donor kidney.
expression of endothelial adhesion molecules.Explosive brain death in experimental rats is associated
Finally, any catecholamines transplanted with the kid-with cytokine production, adhesion molecule expression
ney may have a direct local regulatory effect on the immuneby renal endothelia, and renal inflammation [5]. After
response. They may facilitate Th2 responses [10] that,
in some studies, are associated with allograft tolerance.
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